OpenPresolicitation
2-PAM Autoinjectors Project Bioshield
BARDA - ASPR / DAAPPO / BARDA DCMAHEALTH AND HUMAN SERVICES, DEPARTMENT OF / OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE / BARDA - ASPR / DAAPPO / BARDA DCMA
AI quick read
Get a plain-English summary, the key facts a bidder needs, and who it's a fit for.
- Posted
- Jun 2, 2026
- Response deadline
- Jun 16, 2026, 5:00 PM EDT
- Due in 10 days
- Value
- —
- Category
- R&D — Biotechnology
- NAICS
- 541714
- PSC / Class
- AB12
- Set-aside
- —
- Place of performance
- Washington, District of Columbia
- Solicitation #
- 75A50126R00002
- Archive date
- Jul 1, 2026
Search tags
Market context
- Open in NAICS 541714
- 89
- 7 in District of Columbia
- Typical award (NAICS)
- $4,000,000
- median of 8 awards
- Recent winners
- —
Description
This is a presoliciation notice for the following: BARDA seeks late-stage clinical development, regulatory approval for 2-PAM autoinjectors (as a drug/device combination product) to treat organophosphate (OP) poisoning, including nerve agents, in adult and pediatric populations, and procurement of 2-PAM autoinjectors for the SNS/CHEMPACK Program.